National Association of Testing Authorities, Australia
Scope of Accreditation
Translational Genomics and Epigenomics Laboratory
Site
BEACON Biomarkers Laboratory-Austin
BEACON Biomarkers Laboratory
Accreditation No.
19912
Site No.
23962
Date of Accreditation
21 Dec 2017
Address
Level 8, Lance Townsend Building, Austin Hospital, 145 Studley Road
Heidelberg, VIC 3084
Australia
Contact
Availability
Services available to external clients
Supervision
Not Applicable
Scope of Accreditation
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Service | Product | Determinant |
---|---|---|
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood; Formalin-fixed paraffin-embedded (FFPE) tissues | Blood borne tumours; Breast cancer; Solid tumours |
Molecular genetics - DNA extraction | Blood; Formalin-fixed paraffin-embedded (FFPE) tissues | Viable DNA; Viable DNA for sequencing |
Molecular genetics - Detection and characterisation of cell free RNA (cfRNA)/cell free DNA (cfDNA)/cell free TNA (cfTNA) in cancer screening and/or cancer genetic testing | Blood | Nucleic acid analysis for specific variants |
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Blood; Formalin-fixed paraffin-embedded (FFPE) tissues | BRCA1 methylation; Blood borne tumours; Inherited cancer syndromes; Nucleic acid analysis for specific variants; Solid tumours |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
19912
Site No.
23962
Print date
04 Oct 2024